Cleared Traditional

K801670 - NDI-IKE EMG

K801670 is an FDA 510(k) clearance for NDI-IKE EMG, manufactured by Neurodiagnostics, Inc.. The device is a Class 2 Neurology device with product code GWK cleared through the Traditional 510(k) pathway after a 13-day FDA review.

K801670 · Neurodiagnostics, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1980
Decision
13d
Days
Class 2
Risk

K801670 is an FDA 510(k) clearance for the NDI-IKE EMG. Classified as Conditioner, Signal, Physiological (product code GWK), Class II - Special Controls.

Submitted by Neurodiagnostics, Inc. (Mchenry, US). The FDA issued a Cleared decision on August 4, 1980 after a review of 13 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1845 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Neurodiagnostics, Inc. devices

FDA 510(k) Submission Details - K801670

510(k) Number K801670 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 1980
Decision Date August 04, 1980
Days to Decision 13 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
135d faster than avg
Panel avg: 148d · This submission: 13d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWK Device Classification - Class 2, Special Controls

Product Code GWK Conditioner, Signal, Physiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1845
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWK Conditioner, Signal, Physiological

All 13
Devices cleared under the same product code (GWK) and FDA review panel - the closest regulatory comparables to K801670.
NEUROTRAC
K841110 · Interspec, Inc. · Apr 1984
EVOKED RESPONSE STIMULATORS
K803226 · Bio-Logic Systems Corp. · Feb 1981
PATHFINDER ELECTRODIAGNOSTIC SYSTEM
K801604 · Nicolet Biomedical Instruments · Aug 1980
AUDIO MONITOR-MODEL 8309
K780538 · Life-Tech Instruments, Inc. · Apr 1978
FIBERSCOPIC SCOPE RECORDER SYSTEM
K770782 · Elmed, Inc. · May 1977